Bioequivalence and Adhesion of a Rotigotine Patch in Healthy Subjects

Clinical trial NCT07769359 · COMPLETED

Trial details

NCT number: NCT07769359
Sponsor: Amarin Technologies S.A.U.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence Adhesion Adverse Effects

Start date: 2025-12-04
Primary completion: 2025-12-17
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.